A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Shuzhen Wang et al.|Alzheimer s Research & Therapy|2021Cited by 200
Enriched environment attenuates hippocampal theta and gamma rhythms dysfunction in chronic cerebral hypoperfusion via improving imbalanced neural afferent levelsJiaxin Zheng, Junjian Zhang|Frontiers in Cellular Neuroscience|2023Cited by 3